Henry Schein Cash Flow from Investing Activities 2010-2024 | HSIC

Henry Schein annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • Henry Schein cash flow from investing activities for the quarter ending March 31, 2024 was $-0.072B, a 84.62% increase year-over-year.
  • Henry Schein cash flow from investing activities for the twelve months ending March 31, 2024 was $-2.355B, a 302.56% increase year-over-year.
  • Henry Schein annual cash flow from investing activities for 2023 was $-1.135B, a 311.23% increase from 2022.
  • Henry Schein annual cash flow from investing activities for 2022 was $-0.276B, a 59.23% decline from 2021.
  • Henry Schein annual cash flow from investing activities for 2021 was $-0.677B, a 488.7% increase from 2020.
Henry Schein Annual Cash Flow Investing
(Millions of US $)
2023 $-1,135
2022 $-276
2021 $-677
2020 $-115
2019 $-424
2018 $-193
2017 $-342
2016 $-316
2015 $-260
2014 $-517
2013 $-267
2012 $-270
2011 $-193
2010 $-388
2009 $-99
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $8.879B $12.339B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $74.039B 20.77
Becton Dickinson (BDX) United States $67.041B 18.97
Cardinal Health (CAH) United States $24.179B 13.83
West Pharmaceutical Services (WST) United States $24.141B 43.27
Align Technology (ALGN) United States $19.363B 37.39
Cooper (COO) United States $18.745B 27.70
Labcorp (LH) United States $16.431B 14.14
DENTSPLY SIRONA (XRAY) United States $5.816B 15.06
Merit Medical Systems (MMSI) United States $4.715B 25.84
CONMED (CNMD) United States $2.354B 21.35
Patterson (PDCO) United States $2.203B 10.55
STAAR Surgical (STAA) United States $2.040B 78.36
Atrion (ATRI) United States $0.810B 43.26
Lifevantage (LFVN) United States $0.097B 12.48
Pro-Dex (PDEX) United States $0.067B 33.98
Biolase (BIOL) United States $0.006B 0.00